Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.888 |
High Similarity |
NPD3027 |
Phase 3 |
0.887 |
High Similarity |
NPD228 |
Approved |
0.8672 |
High Similarity |
NPD1613 |
Approved |
0.8672 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8609 |
High Similarity |
NPD2684 |
Approved |
0.8559 |
High Similarity |
NPD5283 |
Phase 1 |
0.84 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8359 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8319 |
Intermediate Similarity |
NPD7843 |
Approved |
0.8281 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8264 |
Intermediate Similarity |
NPD7157 |
Approved |
0.8226 |
Intermediate Similarity |
NPD5846 |
Approved |
0.8226 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.822 |
Intermediate Similarity |
NPD3022 |
Approved |
0.822 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8145 |
Intermediate Similarity |
NPD1357 |
Approved |
0.814 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.812 |
Intermediate Similarity |
NPD968 |
Approved |
0.8106 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.8106 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.8062 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.8051 |
Intermediate Similarity |
NPD290 |
Approved |
0.7967 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7939 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7899 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7891 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7842 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD291 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5735 |
Approved |
0.777 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7761 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7744 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7714 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7704 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7681 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7664 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7664 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7664 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7652 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7652 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7609 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7609 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7594 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7581 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7581 |
Intermediate Similarity |
NPD821 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7565 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7565 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7565 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7557 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7557 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7557 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7556 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7556 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7538 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7538 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7535 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7518 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7518 |
Intermediate Similarity |
NPD4237 |
Approved |
0.75 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD8651 |
Approved |
0.75 |
Intermediate Similarity |
NPD1182 |
Approved |
0.75 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7481 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.748 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.748 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7465 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7465 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7463 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD9365 |
Approved |
0.745 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7424 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7376 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7364 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7364 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7357 |
Intermediate Similarity |
NPD2154 |
Approved |
0.7357 |
Intermediate Similarity |
NPD2155 |
Approved |
0.7357 |
Intermediate Similarity |
NPD2156 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7351 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD1840 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3052 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3054 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7329 |
Intermediate Similarity |
NPD52 |
Approved |
0.7328 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7324 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.7319 |
Intermediate Similarity |
NPD3597 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD1818 |
Approved |
0.7313 |
Intermediate Similarity |
NPD1817 |
Approved |
0.7313 |
Intermediate Similarity |
NPD1820 |
Approved |
0.7313 |
Intermediate Similarity |
NPD1819 |
Approved |
0.731 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7299 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7266 |
Intermediate Similarity |
NPD2557 |
Approved |
0.7266 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7266 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7259 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7252 |
Intermediate Similarity |
NPD9384 |
Approved |
0.7252 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7252 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7252 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7252 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7246 |
Intermediate Similarity |
NPD3531 |
Approved |
0.7246 |
Intermediate Similarity |
NPD3532 |
Approved |
0.7246 |
Intermediate Similarity |
NPD3530 |
Approved |
0.7244 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7244 |
Intermediate Similarity |
NPD27 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7231 |
Intermediate Similarity |
NPD3091 |
Approved |
0.723 |
Intermediate Similarity |
NPD3686 |
Approved |
0.723 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3166 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3165 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6179 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD3164 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3167 |
Approved |
0.7218 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7218 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7218 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7218 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7218 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7203 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD556 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7194 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7194 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1511 |
Approved |
0.719 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7177 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7176 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3056 |
Clinical (unspecified phase) |
0.7172
|
Intermediate Similarity |
NPD6190 |
Approved |